Page last updated: 2024-12-05

isonicotinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Isonicotinamide is a pyridine derivative and a structural isomer of nicotinamide. It is a colorless, crystalline solid that is soluble in water and ethanol. Isonicotinamide is an important precursor to the synthesis of isoniazid, a widely used anti-tuberculosis drug. Isonicotinamide has also been studied for its potential use in treating other conditions, such as Alzheimer's disease and cancer. Research has shown that isonicotinamide can inhibit the growth of cancer cells and may also have neuroprotective effects. The compound's importance stems from its role in the synthesis of isoniazid and its potential applications in treating a range of diseases.'

isonicotinamide : A pyridinecarboxamide that is the monocarboxylic acid amide derivative of isonicotinic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID15074
CHEMBL ID271717
CHEBI ID6031
SCHEMBL ID44995
MeSH IDM0089768

Synonyms (65)

Synonym
nsc 82353
5-22-02-00195 (beilstein handbook reference)
4h3bh6yx9q ,
unii-4h3bh6yx9q
BB 0241857
brn 0002173
einecs 215-926-2
gamma-pyridinecarboxamide
4-carbamoylpyridine
pyridine-4-carboxylic acid amide
CHEBI:6031 ,
4pyrcon
pyridine-4-carboxamide
4-pyridinecarboxamide
nsc-82353
nsc82353
.gamma.-pyridinecarboxamide
isonicotinic acid amide
ISN ,
isonicotinate amide
isonicotineamide
isonicotinamide
1453-82-3
C02421
isonicotinamide, reagentplus(r), 99%
AKOS005067580
I0135
A808358
NCGC00248572-01
cas-1453-82-3
NCGC00257784-01
dtxcid50756
dtxsid3020756 ,
tox21_200230
CHEMBL271717
FT-0627425
AM20061681
isoniacinamide
4-picolinamide
4-(aminocarbonyl)pyridine
isoniazid impurity b [ep impurity]
isoniacinamide [inci]
BRD-K37606513-001-01-4
SCHEMBL44995
4-carbamoyl-pyridine
pyridine 4-carboxamide
STR00561
J-521552
F0001-0518
mfcd00006432
D70516
isonicotinamide, vetec(tm) reagent grade, 98%
J-008098
isonicotinamide : form i
4-pyridine-carboxamide
Q192429
STL183248
SY018471
A884626
CS-W013559
EN300-370555
isonicotinamide--d4
HY-W012843
Z33546454
PD065622

Research Excerpts

Overview

Isonicotinamide is a molecule that is known to form many co-crystals. It stimulates yeast Sir2 deacetylase activity in vitro by alleviating the NAM inhibition.

ExcerptReferenceRelevance
"Isonicotinamide (INAM) is an isostere of NAM that stimulates yeast Sir2 deacetylase activity in vitro by alleviating the NAM inhibition."( Isonicotinamide enhances Sir2 protein-mediated silencing and longevity in yeast by raising intracellular NAD+ concentration.
Maqani, N; McClure, JM; Smith, JS; Wierman, MB, 2012
)
2.54
"Isonicotinamide is a molecule that is known to form many co-crystals."( Unusual co-crystal of isonicotinamide: the structural landscape in crystal engineering.
Desiraju, GR; Tothadi, S, 2012
)
1.41

Bioavailability

ExcerptReferenceRelevance
" The cocrystals outperformed QUE dihydrate with increases in bioavailability up to nearly 10-fold."( Cocrystals of quercetin with improved solubility and oral bioavailability.
Kavuru, P; Shytle, RD; Smith, AJ; Wojtas, L; Zaworotko, MJ, 2011
)
0.37
" Noticeably, the in vitro and in vivo studies revealed that co-crystal 1 possesses improved dissolution rate and superior bioavailability on animal model."( Improving the dissolution and bioavailability of 6-mercaptopurine via co-crystallization with isonicotinamide.
Chen, C; Lin, Y; Mei, X; Pan, G; Wang, JR; Yu, X; Zhou, C, 2015
)
0.64
"012mg/ml 23oC) and low oral bioavailability (about 35-65% for a once 10mg dose)."( Dissolution rate enhancement of new co-crystals of ezetimibe with maleic acid and isonicotinamide.
Kai, S; Li Na, D; Ling, F; Man, Z; Wen, L; Xiao-Hui, Z; Yan-Jie, H; Yu-Zhen, Y, 2019
)
0.74
" Thus, proving cocrystallization to be a potential solution to the solubility limited bioavailability problems of diacerein."( Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
Chadha, R; Chakraborti, S; Grewal, MK; Jindal, A; Tomar, S, 2020
)
0.56
"In the current study, co-crystals of naringenin-isonicotinamide (NGN-INT) were prepared, and effects of PVP or HPMC on precipitation rate, supersaturation, and bioavailability of NGN were explored."( HPMC improves protective effects of naringenin and isonicotinamide co-crystals against abdominal aortic aneurysm.
Anwaier, G; Di, C; Hu, R; Huang, Y; Qi, R; Wang, A; Wang, Q; Wang, Y; Yang, X; Zhang, X, 2022
)
1.23
" The supersaturation-prolonging effect of HPMC further enhanced bioavailability and anti-AAA effects of NGN-INT."( HPMC improves protective effects of naringenin and isonicotinamide co-crystals against abdominal aortic aneurysm.
Anwaier, G; Di, C; Hu, R; Huang, Y; Qi, R; Wang, A; Wang, Q; Wang, Y; Yang, X; Zhang, X, 2022
)
0.97
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyridinecarboxamideA member of the class of pyridines that is a substituted pyridine in which at least one of the substituents is a carboxamide or N-substituted caraboxamide group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency20.63860.006038.004119,952.5996AID1159521; AID1159523
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1280567Inhibition of Mycobacterium tuberculosis PTPB expressed in Escherichia coli BL21/DE3 cells using pNPP as substrate at 200 uM after 5 mins by spectrophotometry2015ACS medicinal chemistry letters, Dec-10, Volume: 6, Issue:12
Cefsulodin Inspired Potent and Selective Inhibitors of mPTPB, a Virulent Phosphatase from Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (81)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (9.88)18.7374
1990's4 (4.94)18.2507
2000's18 (22.22)29.6817
2010's37 (45.68)24.3611
2020's14 (17.28)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.36 (24.57)
Research Supply Index4.44 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index49.01 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.38%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other82 (97.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]